Correlation Between Berkshire Hathaway and Auxly Cannabis
Can any of the company-specific risk be diversified away by investing in both Berkshire Hathaway and Auxly Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Berkshire Hathaway and Auxly Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Berkshire Hathaway CDR and Auxly Cannabis Group, you can compare the effects of market volatilities on Berkshire Hathaway and Auxly Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Berkshire Hathaway with a short position of Auxly Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Berkshire Hathaway and Auxly Cannabis.
Diversification Opportunities for Berkshire Hathaway and Auxly Cannabis
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Berkshire and Auxly is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Berkshire Hathaway CDR and Auxly Cannabis Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Auxly Cannabis Group and Berkshire Hathaway is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Berkshire Hathaway CDR are associated (or correlated) with Auxly Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Auxly Cannabis Group has no effect on the direction of Berkshire Hathaway i.e., Berkshire Hathaway and Auxly Cannabis go up and down completely randomly.
Pair Corralation between Berkshire Hathaway and Auxly Cannabis
Assuming the 90 days trading horizon Berkshire Hathaway CDR is expected to under-perform the Auxly Cannabis. But the stock apears to be less risky and, when comparing its historical volatility, Berkshire Hathaway CDR is 8.04 times less risky than Auxly Cannabis. The stock trades about -0.2 of its potential returns per unit of risk. The Auxly Cannabis Group is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 8.50 in Auxly Cannabis Group on May 7, 2025 and sell it today you would earn a total of 5.50 from holding Auxly Cannabis Group or generate 64.71% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Berkshire Hathaway CDR vs. Auxly Cannabis Group
Performance |
Timeline |
Berkshire Hathaway CDR |
Auxly Cannabis Group |
Berkshire Hathaway and Auxly Cannabis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Berkshire Hathaway and Auxly Cannabis
The main advantage of trading using opposite Berkshire Hathaway and Auxly Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Berkshire Hathaway position performs unexpectedly, Auxly Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Auxly Cannabis will offset losses from the drop in Auxly Cannabis' long position.Berkshire Hathaway vs. Current Water Technologies | Berkshire Hathaway vs. Nano One Materials | Berkshire Hathaway vs. Sangoma Technologies Corp | Berkshire Hathaway vs. Labrador Iron Ore |
Auxly Cannabis vs. Auxly Cannabis Group | Auxly Cannabis vs. OrganiGram Holdings | Auxly Cannabis vs. Decibel Cannabis | Auxly Cannabis vs. Medipharm Labs Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
CEOs Directory Screen CEOs from public companies around the world | |
Stocks Directory Find actively traded stocks across global markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |